•
Jun 30, 2022

Acasti Pharma Q1 2023 Earnings Report

EPS
-$0.61
Previous year: -$0.12
+408.3%
Cash and Equivalents
$38.4M
Previous year: $41M
-6.3%
Total Assets
$125M
Previous year: $60.5M
+106.7%

Acasti Pharma

Acasti Pharma